WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-54 Cr | ₹409 Cr | ₹334 Cr | ₹-315 Cr | ₹-71 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-54 Cr |
| Mar2025 | ₹409 Cr |
| Mar2024 | ₹334 Cr |
| Mar2023 | ₹-315 Cr |
| Mar2022 | ₹-71 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-54 Cr | Negative | |
| Mar2025 | ₹409 Cr | 22.46 | |
| Mar2024 | ₹334 Cr | Positive | |
| Mar2023 | ₹-315 Cr | Negative | |
| Mar2022 | ₹-71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹30,018.6 Cr | -6.4% | -0.2% | 23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -6.4% |
-0.2% |
23.3% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses